CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 101 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $64,118,000 | -40.8% | 2,040,021 | -11.3% | 2.98% | -31.1% |
| Q4 2019 | $108,353,000 | +1282.4% | 2,300,000 | +89.6% | 4.32% | +806.5% |
| Q3 2019 | $7,838,000 | -49.8% | 1,213,274 | -4.6% | 0.48% | -46.8% |
| Q2 2019 | $15,616,000 | -9.4% | 1,271,685 | -0.0% | 0.90% | -23.0% |
| Q1 2019 | $17,231,000 | +237.9% | 1,271,687 | 0.0% | 1.16% | +181.4% |
| Q4 2018 | $5,099,000 | -40.4% | 1,271,687 | 0.0% | 0.41% | -25.5% |
| Q3 2018 | $8,558,000 | – | 1,271,687 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |